Clinical Trial

Omega-3 Supplementation for Pediatric Migraine

Completed
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the biochemical and clinical effects of omega-3 polyunsaturated fatty acid (PUFA) supplementation in youth suffering from migraine, including its effects on migraine disability, psychological distress, and overall quality of life. This study duration 12 weeks.
Protocol Amendment History 2 changes
critical Trial completed 2026-07-03
critical Primary endpoint(s) modified 2026-07-03
Trial Details
NCT Number NCT06899074
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: Nutrition Obesity Research Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Migraine
Enrollment 57 participants
Start Date 2025-04-17
Primary Completion 2026-03-18 (estimated)
Study Completion 2026-03-18 (estimated)
Updated on ClinicalTrials.gov 2026-07-02